← Leaderboards
Fariba Behbod
Baylor College Of Medicine
$4,652,758
Attributed
$5,714,954
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $989.7K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,714,954 · 8
By mechanism
R01$3,822,180 · 2
R00$739,530 · 1
R21$681,223 · 2
K99$272,160 · 1
F32$170,380 · 1
P20$29,481 · 1
Top collaborators
- Nikki Cheng6 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Heather L Machado$3,818,678
- Jianming Xu$13,357,961
- Ali J. Marian$17,600,929
- Jeffrey Rosen$27,294,929
- Hugo Villanueva$117,864
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularMammary GlandIn VivoBaseTumorTransplantationPhenotypeNoninfiltrating Intraductal CarcinomaMediatingLesionCell LineWomanMalignant Breast NeoplasmMouse ModelMammary NeoplasmsBreastSignal TransductionNormal Tissue MorphologySamplingLeadMalignant NeoplasmsEpithelial CellsImmunocompromised Host
Grant awards (23)
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS$550,284
R01 · FY2019 · CA · contact PI
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS$571,242
R01 · FY2018 · CA · contact PI
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS$576,261
R01 · FY2017 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$413,485
R01 · FY2017 · CA
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$412,331
R01 · FY2016 · CA
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$66,378
R01 · FY2016 · CA
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$414,124
R01 · FY2015 · CA
(PQC3) Essential Role of BCL9 in Promotion of Human DCIS to Invasive Ductal Carci$164,213
R21 · FY2015 · CA · contact PI
Elucidating cellular heterogeneity among cancer stem cells by Raman Spectroscopy$145,059
R21 · FY2015 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$404,660
R01 · FY2014 · CA
(PQC3) Essential Role of BCL9 in Promotion of Human DCIS to Invasive Ductal Carci$197,055
R21 · FY2014 · CA · contact PI
Elucidating cellular heterogeneity among cancer stem cells by Raman Spectroscopy$174,896
R21 · FY2014 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$413,415
R01 · FY2013 · CA
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.$241,530
R00 · FY2011 · CA · contact PI
ROLE OF MIR146B IN SURVIVAL & SELF RENEWAL OF MAMMARY ALVEOLAR PROGENITOR CELLS$29,481
P20 · FY2011 · RR · contact PI
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.$249,000
R00 · FY2010 · CA · contact PI
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.$249,000
R00 · FY2009 · CA · contact PI
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.$119,070
K99 · FY2008 · CA · contact PI
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.$17,010
K99 · FY2008 · CA · contact PI
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.$136,080
K99 · FY2007 · CA · contact PI
Stem Cells in Normal Mammary Development and Cancer$57,536
F32 · FY2005 · CA
Stem Cells in Normal Mammary Development and Cancer$56,536
F32 · FY2004 · CA
Stem Cells in Normal Mammary Development and Cancer$56,308
F32 · FY2003 · CA